| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.17 (0%) | 🛒 Add to cart |
| 60 | $1.07 | $82.33 $64.26 (22%) | 🛒 Add to cart |
| 90 | $0.97 | $123.50 $87.35 (29%) | 🛒 Add to cart |
| 120 | $0.93 | $164.67 $111.45 (32%) | 🛒 Add to cart |
| 180 | $0.88 | $247.00 $157.64 (36%) | 🛒 Add to cart |
| 270 | $0.84 | $370.50 $227.92 (38%) | 🛒 Add to cart |
| 360 | $0.83
Best per pill | $494.00 $298.21 (40%) | 🛒 Add to cart |
Similar products
More info:
Bupropion SR: Effective Relief for Major Depressive Disorder
Bupropion SR (sustained-release) is a widely prescribed antidepressant belonging to the norepinephrine-dopamine reuptake inhibitor (NDRI) class. It is specifically formulated to alleviate symptoms of major depressive disorder by modulating key neurotransmitters in the brain, offering a therapeutic option with a distinct mechanism compared to SSRIs. Its sustained-release delivery ensures stable plasma concentrations, supporting consistent mood stabilization and reducing dosing frequency. Clinically, it is valued for its favorable side effect profile, particularly the low incidence of sexual dysfunction and weight gain.
Bupropion: Effective Relief for Depression and Smoking Cessation
Bupropion is a widely prescribed antidepressant medication belonging to the class of norepinephrine-dopamine reuptake inhibitors (NDRIs). Unlike many other antidepressants, it does not significantly affect serotonin levels, which contributes to its unique side effect profile and therapeutic benefits. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. Its mechanism of action involves increasing the levels of norepinephrine and dopamine in the brain, neurotransmitters associated with mood regulation, motivation, and pleasure.
Champix: Clinically Proven Smoking Cessation Support
Champix (varenicline) is a prescription medication specifically designed to aid smoking cessation by targeting nicotine receptors in the brain. It functions as a partial agonist, meaning it both reduces withdrawal symptoms and diminishes the pleasurable effects of smoking. This dual-action approach supports individuals in breaking the psychological and physical dependence on nicotine, making it a cornerstone in structured quit attempts under medical supervision. Features Active ingredient: Varenicline (as varenicline tartrate) Available in 0.
Contrave: Comprehensive Weight Management with Dual-Action Therapy
Contrave represents a significant advancement in the pharmacological management of chronic weight issues, combining two established medications to target both appetite control and reward pathways in the brain. This prescription medication is specifically designed for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity, serving as an adjunct to reduced-calorie diet and increased physical activity. Its unique mechanism addresses multiple physiological factors contributing to weight regulation, offering a scientifically-backed approach to sustainable weight loss.
EMSAM: A Transdermal MAOI for Treatment-Resistant Depression
EMSAM (selegiline transdermal system) is a monoamine oxidase inhibitor (MAOI) delivered through a transdermal patch, offering a novel mechanism of action for adults with major depressive disorder (MDD) who have not achieved an adequate response from other antidepressant therapies. By bypassing first-pass metabolism, EMSAM provides targeted delivery of selegiline, a potent and irreversible inhibitor of monoamine oxidase, while potentially mitigating the need for the strict dietary tyramine restrictions historically associated with oral MAOIs at its lowest dosage.
Nolvadex: The Gold Standard in Estrogen Receptor Management
Nolvadex (tamoxifen citrate) represents a cornerstone in endocrine therapy, specifically engineered as a selective estrogen receptor modulator (SERM). Its primary mechanism involves competitively binding to estrogen receptors in target tissues, thereby blocking the proliferative effects of estrogen. This targeted action makes it an indispensable agent in both therapeutic and preventative oncology protocols. Its well-documented efficacy and extensive clinical history have solidified its status as a first-line treatment option for hormone-receptor-positive breast cancer.
Sustiva: Advanced NNRTI Therapy for Effective HIV-1 Management
Sustiva (efavirenz) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in combination with other antiretroviral agents. As a cornerstone of many highly active antiretroviral therapy (HAART) regimens, it works by binding directly to reverse transcriptase, blocking RNA- and DNA-dependent DNA polymerase activities. This action inhibits viral replication, reduces viral load, and supports immune reconstitution in appropriate patient populations. Clinical studies have demonstrated its efficacy in both treatment-naïve and experienced individuals when used as part of a comprehensive therapeutic strategy.
Wellbutrin SR: Effective Relief for Major Depressive Disorder
Wellbutrin SR (bupropion hydrochloride sustained-release) is a widely prescribed antidepressant belonging to the aminoketone class, distinct from commonly used SSRIs and SNRIs. It functions primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), offering a unique mechanism of action that avoids serotonin-related side effects such as weight gain or sexual dysfunction. Clinically indicated for the treatment of major depressive disorder (MDD) and seasonal affective disorder (SAD), it is valued for its favorable side effect profile and energizing properties.
Wellbutrin: A Clinically Proven Treatment for Major Depressive Disorder
Wellbutrin (bupropion hydrochloride) is a norepinephrine-dopamine reuptake inhibitor (NDRI) antidepressant medication distinguished by its unique pharmacological profile. Unlike many conventional antidepressants that primarily target serotonin systems, Wellbutrin works by inhibiting the neuronal reuptake of dopamine and norepinephrine, offering an alternative mechanism of action for patients who may not tolerate or respond adequately to selective serotonin reuptake inhibitors (SSRIs). This medication is FDA-approved for the treatment of major depressive disorder (MDD) and has demonstrated efficacy in preventing seasonal affective disorder (SAD) and aiding smoking cessation.